Advanced search
Publication Cover
Hospital Practice Volume 41, 2013 - Issue 2
Submit an article Journal homepage
126
Views
15
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes Management in the Hospital Setting and Transitioning Back to Primary Care

Combination Therapy With DPP-4 Inhibitors and Insulin in Patients With Type 2 Diabetes Mellitus: What Is the Evidence?

Bernard Charbonnel Department of Endocrinology, University of Nantes, Hopital Laënnec, Nantes, France
, MD,
Anja Schweizer Novartis Pharma AG, Basel, Switzerland
, PhD &
Sylvie Dejager Novartis Pharma SAS, Rueil Malmaison, Paris, FranceCorrespondence[email protected]
, MD, PhD
Pages 93-107 | Published online: 13 Mar 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Bruno Detournay, Serge Halimi, Julien Robert, Céline Deschaseaux & Sylvie Dejager. (2015) Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database. Vascular Health and Risk Management 11, pages 417-425.
Read now
Alfred Penfornis, Béatrice Fiquet, Jean Frédéric Blicklé & Sylvie Dejager. (2015) Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study. Diabetes, Metabolic Syndrome and Obesity 8, pages 303-313.
Read now
Kamran MA Aziz. (2015) Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients. Diabetes, Metabolic Syndrome and Obesity 8, pages 207-211.
Read now
André J Scheen. (2015) A review of gliptins for 2014. Expert Opinion on Pharmacotherapy 16:1, pages 43-62.
Read now

Articles from other publishers (11)

Kunika Saini, Smriti Sharma & Yousuf Khan. (2023) DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature. Frontiers in Molecular Biosciences 10.
Crossref
Yu Mi Kang, Chang Hee Jung, Seung-Hwan LeeSang-Wook KimKee-Ho SongSin Gon KimJae Hyeon KimYoung Min ChoTae Sun ParkBon Jeong KuGwanpyo KohDol Mi KimByung-Wan Lee & Joong-Yeol Park. (2019) Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea. Diabetes & Metabolism Journal 43:4, pages 432.
Crossref
Ying Cao, Fang Gao, Qian Zhang, Lingling Xu, Qian Wan, Wenqi Li, Jimin Li, Ling Wang & Yaoming Xue. (2016) Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes. Journal of Diabetes 9:5, pages 502-509.
Crossref
Timothy J. Church & Stuart T. Haines. (2016) Treatment Approach to Patients With Severe Insulin Resistance. Clinical Diabetes 34:2, pages 97-104.
Crossref
Gillian M. Keating. (2015) Alogliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus. Drugs 75:7, pages 777-796.
Crossref
Wendela Lucia de Ranitz-Greven, Joline Wilhelma Johanna Beulens, Lette Birgit Elisabeth Anne Hoeks, Gerdien Belle-van Meerkerk, Douwe Hedde Biesma & Harold Wessel de Valk. (2014) Patients with Type 2 Diabetes Mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin. BMC Research Notes 7:1.
Crossref
W. Lane, S. Weinrib, J. Rappaport & C. Hale. (2014) The effect of addition of liraglutide to high-dose intensive insulin therapy: a randomized prospective trial. Diabetes, Obesity and Metabolism 16:9, pages 827-832.
Crossref
Philip HomeMatthew Riddle, William T. Cefalu, Clifford J. BaileyReinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal & Itamar Raz. (2014) Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?. Diabetes Care 37:6, pages 1499-1508.
Crossref
Gillian M. Keating. (2014) Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus. Drugs 74:5, pages 587-610.
Crossref
Aljoša Bavec. (2014) (Poly)peptide-based therapy for diabetes mellitus: Insulins versus incretins. Life Sciences 99:1-2, pages 7-13.
Crossref
Serge Halimi, Marc Levy, Dominique Huet, Stéphane Quéré & Sylvie Dejager. (2013) Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study. Diabetes Therapy 4:2, pages 385-398.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.